Annual Net Margin
-240.20%
-61.51%-34.42%
31 December 2023
Summary:
Lineage Cell Therapeutics annual net profit margin is currently -240.20%, with the most recent change of -61.51% (-34.42%) on 31 December 2023. During the last 3 years, it has risen by +2431.08% (+91.01%). LCTX annual net margin is now -74.72% below its all-time high of -137.48%, reached on 31 December 2007.LCTX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
-80.29%
+328.80%+80.37%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly net profit margin is currently -80.29%, with the most recent change of +328.80% (+80.37%) on 30 September 2024. Over the past year, it has increased by +490.34% (+85.93%). LCTX quarterly net margin is now -1.83% below its all-time high of -78.85%, reached on 31 December 2006.LCTX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.4% | +85.9% |
| 3 y3 years | +91.0% | +77.4% |
| 5 y5 years | +92.6% | +98.9% |
LCTX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -34.4% | +91.0% | at high | +97.3% |
| 5 y | 5 years | -34.4% | +92.6% | at high | +98.9% |
| alltime | all time | -74.7% | +100.0% | -1.8% | +100.0% |
Lineage Cell Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -80.29%(-80.4%) |
| June 2024 | - | -409.09%(-9.7%) |
| Mar 2024 | - | -453.05%(+98.1%) |
| Dec 2023 | -240.20%(+34.4%) | -228.69%(-59.9%) |
| Sept 2023 | - | -570.63%(+251.9%) |
| June 2023 | - | -162.14%(-11.5%) |
| Mar 2023 | - | -183.24%(-44.8%) |
| Dec 2022 | -178.69%(-83.8%) | -331.80%(+63.9%) |
| Sept 2022 | - | -202.44%(+36.3%) |
| June 2022 | - | -148.54%(+9.8%) |
| Mar 2022 | - | -135.33%(-95.5%) |
| Dec 2021 | -1104.18%(-58.7%) | -3019.79%(+750.0%) |
| Sept 2021 | - | -355.27%(-67.3%) |
| June 2021 | - | -1085.71%(+124.7%) |
| Mar 2021 | - | -483.28%(-78.7%) |
| Dec 2020 | -2671.28%(+237.2%) | - |
| Sept 2020 | - | -2269.01%(-65.6%) |
| June 2020 | - | -6587.88%(+30.2%) |
| Mar 2020 | - | -5059.64%(+839.2%) |
| Dec 2019 | -792.22%(-75.6%) | -538.70%(-92.9%) |
| Sept 2019 | - | -7605.99%(-36.7%) |
| June 2019 | - | -12.01 K%(-54.3%) |
| Dec 2018 | -3247.88%(+191.4%) | -26.29 K%(+3679.5%) |
| June 2018 | - | -695.54%(-95.9%) |
| Mar 2018 | - | -16.95 K%(+34.0%) |
| Dec 2017 | -1114.73%(-39.9%) | -12.64 K%(+313.4%) |
| June 2017 | - | -3058.01%(+356.7%) |
| Dec 2016 | - | -669.53%(-77.1%) |
| Mar 2016 | - | -2920.14%(+20.7%) |
| Dec 2015 | -1854.42%(-0.8%) | -2418.74%(+49.1%) |
| Sept 2015 | - | -1622.14%(-4.3%) |
| June 2015 | - | -1694.23%(-5.8%) |
| Mar 2015 | - | -1799.47%(-24.3%) |
| Dec 2014 | -1870.16%(+21.9%) | -2378.43%(+56.2%) |
| Sept 2014 | - | -1522.65%(-25.3%) |
| June 2014 | - | -2038.54%(+23.6%) |
| Mar 2014 | - | -1649.57%(+6.0%) |
| Dec 2013 | -1533.83%(+21.2%) | -1556.08%(-4.3%) |
| Sept 2013 | - | -1626.20%(+12.6%) |
| June 2013 | - | -1443.98%(-2.0%) |
| Mar 2013 | - | -1472.73%(+26.4%) |
| Dec 2012 | -1265.64%(+27.7%) | -1164.68%(+32.0%) |
| Sept 2012 | - | -882.33%(-41.6%) |
| June 2012 | - | -1511.16%(-23.6%) |
| Mar 2012 | - | -1978.22%(+514.8%) |
| Dec 2011 | -990.74%(+21.5%) | - |
| Sept 2011 | - | -321.77%(-41.3%) |
| June 2011 | - | -548.19%(+34.5%) |
| Mar 2011 | - | -407.71%(-28.8%) |
| Dec 2010 | -815.39%(+205.1%) | - |
| Sept 2010 | - | -572.95%(+72.5%) |
| June 2010 | - | -332.18%(+98.3%) |
| Mar 2010 | - | -167.53%(-79.1%) |
| Dec 2009 | -267.22%(+6.3%) | - |
| Sept 2009 | - | -799.73%(+134.9%) |
| June 2009 | - | -340.52%(-33.4%) |
| Mar 2009 | - | -511.63%(-6.7%) |
| Dec 2008 | -251.42%(+82.9%) | -548.57%(+117.4%) |
| Sept 2008 | - | -252.31%(+56.3%) |
| June 2008 | - | -161.43%(+29.2%) |
| Mar 2008 | - | -124.94%(+37.1%) |
| Dec 2007 | -137.48% | -91.15%(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2007 | - | -92.36%(-43.4%) |
| June 2007 | - | -163.27%(-27.6%) |
| Mar 2007 | - | -225.42%(+185.9%) |
| Dec 2006 | -160.46%(-30.1%) | -78.85%(-31.1%) |
| Sept 2006 | - | -114.49%(-75.5%) |
| June 2006 | - | -466.39%(+135.8%) |
| Mar 2006 | - | -197.81%(-10.2%) |
| Dec 2005 | -229.66%(-48.8%) | -220.26%(+27.6%) |
| Sept 2005 | - | -172.63%(-2.8%) |
| June 2005 | - | -177.61%(-53.3%) |
| Mar 2005 | - | -380.25%(+33.2%) |
| Dec 2004 | -448.20%(+43.2%) | -285.51%(+7.6%) |
| Sept 2004 | - | -265.32%(+17.2%) |
| June 2004 | - | -226.41%(-82.0%) |
| Mar 2004 | - | -1257.03%(+431.0%) |
| Dec 2003 | -313.09%(-57.4%) | -236.74%(-69.5%) |
| June 2003 | - | -775.84%(-0.2%) |
| Mar 2003 | - | -777.39%(+83.3%) |
| Dec 2002 | -735.09%(-69.5%) | -424.00%(-37.1%) |
| Sept 2002 | - | -674.33%(-47.6%) |
| June 2002 | - | -1287.87%(+4.3%) |
| Mar 2002 | - | -1234.22%(+4.9%) |
| Dec 2001 | -2408.44%(-74.3%) | -1177.00%(-52.6%) |
| Sept 2001 | - | -2480.69%(-33.6%) |
| June 2001 | - | -3738.65%(+28.4%) |
| Mar 2001 | - | -2910.96%(+45.5%) |
| Dec 2000 | -9382.43%(+1676.4%) | -2001.03%(-100.0%) |
| Sept 2000 | - | -122.50 M%(>+9900.0%) |
| June 2000 | - | -18.00 K%(-21.8%) |
| Mar 2000 | - | -23.03 K%(+483.5%) |
| Dec 1999 | -528.18%(-100.0%) | -3946.36%(-100.0%) |
| Sept 1999 | - | -230.00 M%(>+9900.0%) |
| June 1999 | - | -166.67%(-16.7%) |
| Mar 1999 | - | -200.00%(-81.8%) |
| Dec 1998 | -210.00 M%(>+9900.0%) | - |
| Sept 1998 | - | -1100.00%(+1110.0%) |
| June 1998 | - | -90.91%(-91.7%) |
| June 1998 | -304.35%(-89.9%) | - |
| Mar 1998 | - | -1100.00%(+633.3%) |
| Dec 1997 | - | -150.00%(-85.0%) |
| Sept 1997 | - | -1000.00%(+100.0%) |
| June 1997 | -3000.00%(+50.0%) | - |
| Mar 1997 | - | -500.00%(-37.5%) |
| Dec 1996 | - | -800.00%(+14.3%) |
| Sept 1996 | - | -700.00%(+16.7%) |
| June 1996 | -2000.00%(-16.7%) | - |
| Mar 1996 | - | -600.00%(0.0%) |
| Dec 1995 | - | -600.00%(+100.0%) |
| Sept 1995 | - | -300.00%(-50.0%) |
| June 1995 | -2400.00%(+60.0%) | - |
| Mar 1995 | - | -600.00%(0.0%) |
| Dec 1994 | - | -600.00%(+20.0%) |
| Sept 1994 | - | -500.00%(+66.7%) |
| June 1994 | -1500.00%(+25.0%) | - |
| Mar 1994 | - | -300.00%(-25.0%) |
| Dec 1993 | - | -400.00%(+33.3%) |
| Sept 1993 | - | -300.00%(+50.0%) |
| June 1993 | -1200.00%(+71.4%) | - |
| Mar 1993 | - | -200.00%(-33.3%) |
| Dec 1992 | - | -300.00%(0.0%) |
| Sept 1992 | - | -300.00%(+50.0%) |
| June 1992 | -700.00% | - |
| Mar 1992 | - | -200.00% |
FAQ
- What is Lineage Cell Therapeutics annual net profit margin?
- What is the all time high annual net margin for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual net margin year-on-year change?
- What is Lineage Cell Therapeutics quarterly net profit margin?
- What is the all time high quarterly net margin for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly net margin year-on-year change?
What is Lineage Cell Therapeutics annual net profit margin?
The current annual net margin of LCTX is -240.20%
What is the all time high annual net margin for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual net profit margin is -137.48%
What is Lineage Cell Therapeutics annual net margin year-on-year change?
Over the past year, LCTX annual net profit margin has changed by -61.51% (-34.42%)
What is Lineage Cell Therapeutics quarterly net profit margin?
The current quarterly net margin of LCTX is -80.29%
What is the all time high quarterly net margin for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly net profit margin is -78.85%
What is Lineage Cell Therapeutics quarterly net margin year-on-year change?
Over the past year, LCTX quarterly net profit margin has changed by +490.34% (+85.93%)